MedTrace Logo

Cell Salvage During Caesarean Section (CSCS)

NCT03429790 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2025-07-18

No results posted yet for this study

Summary

The purposes of this study are:

1. To compare the difference of blood loss of the patients undergoing cesarean section between intraoperative blood recovery and allogeneic blood transfusion.
2. To compare the safety of the two methods.
3. To evaluate the medical cost and the overall cost of the two methods.

Conditions

  • Blood Transfusion

Interventions

COMBINATION_PRODUCT

intra-operative cell salvage

intra-operative cell salvage collects the patient's blood lost during an operation, processes it and returns it to their own circulation.

COMBINATION_PRODUCT

allogeneic blood transfusion

transfuse allogeneic blood to patients if blood transfusion is needed.

Sponsors & Collaborators

  • Wenzhou Medical University

    lead OTHER

Principal Investigators

  • Fang Gao Smith, M.D. · The Second Affiliated Hospital & Yuying Children hospital of Wenzhou Medical University

  • Qingquan Lian, M.D. · The Second Affiliated Hospital & Yuying Children hospital of Wenzhou Medical University

  • Ting LI, M.D. · The Second Affiliated Hospital & Yuying Children hospital of Wenzhou Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-01
Primary Completion
2018-12-31
Completion
2018-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03429790 on ClinicalTrials.gov